Primary Indications
Post-Traumatic Arthritis (Most Common: 30-50% post-Lisfranc)
High-energy Lisfranc injuries result in articular cartilage damage, instability, and progressive arthritis. Failed conservative management with persistent pain, deformity, and functional limitation despite orthotics, activity modification, and injections warrants surgical fusion. Weight-bearing radiographs demonstrate joint space narrowing, subchondral sclerosis, and osteophyte formation. CT scan identifies all involved joints requiring fusion.
Primary Degenerative Osteoarthritis
Idiopathic TMT arthritis typically affects 1st-2nd TMT joints with medial column collapse and flatfoot deformity. Progression causes metatarsalgia, callus formation under 2nd-3rd MT heads, and difficulty with shoe wear. Failed conservative treatment including custom orthotics, rocker-bottom shoes, NSAIDs, and corticosteroid injections indicates need for arthrodesis.
Inflammatory Arthropathy
Rheumatoid arthritis, psoriatic arthritis, and seronegative spondyloarthropathies frequently affect TMT joints causing synovitis, erosions, and progressive deformity. Surgical fusion indicated for failed medical management with persistent pain and deformity despite DMARD therapy. Often requires multi-ray fusion due to panarticular involvement.
Failed Lisfranc ORIF
Hardware failure, loss of reduction, or development of post-traumatic arthritis after ORIF necessitates conversion to arthrodesis. Typically occurs 12-24 months post-injury. Hardware removal with concurrent fusion addresses both symptomatic hardware and arthritis.
Adult-Acquired Flatfoot Deformity (Stage 3-4)
TMT collapse with midfoot break in advanced PTTD causes abduction deformity and medial column instability. Arthrodesis addresses both deformity correction and stabilization when isolated PTTD reconstruction inadequate.
Contraindications
Absolute Contraindications
Active infection at surgical site requires staged treatment with debridement and antibiotics prior to definitive fusion. Severe peripheral vascular disease with non-palpable pulses, ABI less than 0.5, absent pedal perfusion on angiography contraindicates elective reconstruction.
Relative Contraindications
Current smoking increases non-union risk 3-4 fold (15-25% vs 5-15%) - strongly encourage cessation minimum 6 weeks pre-operatively. Poorly controlled diabetes with HbA1c greater than 8% increases infection and non-union risk - optimize medically first. Severe osteoporosis requires bone density optimization and consideration of biologics. Neuropathic arthropathy (Charcot) is relative contraindication requiring specialized techniques including extended fusion, plantar plating, and prolonged immobilization.
Osseous Anatomy
Tarsometatarsal Joint Configuration
The TMT articulation consists of three distinct functional columns. The medial column comprises the 1st TMT joint (medial cuneiform-1st metatarsal base). The middle column includes 2nd TMT (middle/medial cuneiform-2nd MT base) and 3rd TMT (lateral cuneiform-3rd MT base). The lateral column contains 4th TMT (cuboid-4th MT base) and 5th TMT (cuboid-5th MT base). The 2nd MT base is recessed creating a "keystone" effect with bony stability.
Functional Mobility
Classic anatomic studies by Ouzounian and Shereff (1989) demonstrated differential TMT joint motion. Medial and middle columns (1st-3rd TMT) exhibit minimal motion (1-2 degrees sagittal plane) providing rigid lever for propulsion. Lateral column (4th-5th TMT) demonstrates significant mobility (15-20 degrees flexion-extension) allowing forefoot adaptation to terrain. This anatomic difference guides surgical decision-making regarding selective fusion.
Ligamentous Anatomy
The Lisfranc ligament complex provides primary stability. The plantar ligaments are strongest, particularly the plantar Lisfranc ligament connecting medial cuneiform to 2nd MT base (3-5mm thick). Dorsal ligaments are thinner and weaker. Intermetatarsal ligaments connect 2nd-5th MT bases but notably absent between 1st-2nd MT, creating vulnerability.
Neurovascular Anatomy
Dorsalis Pedis Artery
Terminal continuation of anterior tibial artery, passes under inferior extensor retinaculum at ankle level. Runs between EHL (medial) and EDL to 2nd toe (lateral) over navicular and intermediate cuneiform. At TMT level, lies 12-15mm deep between 1st-2nd MT bases on first dorsal interosseous muscle. Gives off first dorsal metatarsal artery, then continues as deep plantar artery penetrating first interspace. Absent or diminutive in 12% (peroneal artery-dominant variant).
Deep Peroneal Nerve
Travels with dorsalis pedis artery immediately lateral. Provides motor branches to EDB and EHB muscles. Terminal sensory branch provides sensation to first webspace. Vulnerable throughout TMT exposure requiring careful identification and protection.
Plantar Neurovascular Bundles
Medial plantar nerve and artery run in superficial medial plantar compartment 8-10mm plantar to medial cuneiform-1st MT joint. Lateral plantar nerve and artery course in lateral compartment plantar to cuboid and lateral column. Both at risk from excessive plantar screw penetration or plantar dissection.
Superficial Peroneal Nerve
Emerges from lateral compartment 10-12cm proximal to ankle, branches provide sensation to dorsal foot. Intermediate dorsal cutaneous nerve runs over dorsum between incisions. At risk during superficial dissection particularly lateral incision.
Muscular Anatomy
Extrinsic Extensors
Extensor hallucis longus (EHL) lies medial over 1st MT. Extensor digitorum longus (EDL) tendons to 2nd-5th toes lie lateral. Neurovascular bundle runs between EHL and EDL to 2nd toe, defining anatomic interval for medial dissection.
Intrinsic Muscles
Extensor digitorum brevis (EDB) originates from calcaneus, muscle belly overlies lateral column and cuboid. May require division for lateral column exposure. Dorsal interossei muscles fill spaces between metatarsals. First dorsal interosseous provides anatomic bed for dorsalis pedis.
Pre-operative Planning
Clinical Assessment
Systematic examination includes pain localization using palpation over each TMT joint to identify symptomatic levels. Drawer test assesses instability by grasping forefoot and translating dorsally/plantarly while stabilizing midfoot. Passive correction of deformity determines flexibility versus fixed deformity. Neurovascular examination documents dorsalis pedis and posterior tibial pulses, capillary refill, sensation. ABI measurement indicated in diabetics, smokers, elderly, or absent pulses.
Imaging Protocol
Weight-bearing AP, lateral, and oblique radiographs demonstrate joint space narrowing, subchondral sclerosis, cyst formation, osteophytes, and alignment. CT scan with coronal, sagittal, and axial reconstructions identifies all arthritic joints, assesses bone stock, evaluates for occult fractures or cysts, and aids fusion planning. MRI generally unnecessary unless soft tissue pathology suspected.
Surgical Planning Decisions
Identify all symptomatic arthritic joints requiring fusion using combined clinical examination and imaging. Isolated 1st TMT fusion for localized arthritis. Combined 1st-2nd-3rd TMT fusion for medial/middle column arthritis (most common pattern). Evaluate lateral column (4th-5th TMT) - fuse ONLY if symptomatic arthritis present due to importance of lateral column mobility. Plan incision placement (single vs dual), fixation strategy (plates vs screws or combined), and need for bone graft.
Positioning and Setup
Patient Positioning
Supine position on radiolucent table. Place 5-10cm bump under ipsilateral buttock to externally rotate leg, facilitating AP fluoroscopy. Knee flexed 30-45 degrees over bolster prevents sciatic nerve stretch and improves ergonomics. Ipsilateral arm across chest. Contralateral leg flat or in lithotomy.
Equipment Setup
C-arm positioned from contralateral side for AP, lateral, and oblique views without repositioning leg. Surgeon stands ipsilateral side. Assistant opposite. Scrub stand at foot. Power equipment (drill, saw, burr) tested and ready. Ensure implants available: 2.7-3.5mm dorsal locking plates (various lengths), 3.5mm cortical screws (20-50mm range), K-wires (0.062 and 1.6mm).
Tourniquet Application
Well-padded thigh tourniquet inflated to 250-300mmHg (systolic BP plus 100mmHg for thigh). Exsanguinate with elevation 2 minutes or Esmarch bandage. Tourniquet time should not exceed 90-120 minutes to prevent tourniquet-related complications and compartment syndrome risk.
Incision and Approach
Dual Incision Technique (Standard for Multi-Ray Fusion)
Medial Incision: 8-10cm longitudinal incision centered over 2nd MT, extending from mid-metatarsal shaft proximally to naviculocuneiform joint. Slightly curved to follow metatarsal contour. Positioned slightly medial to palpable dorsalis pedis pulse to avoid artery. Lateral Incision: 6-8cm longitudinal over 4th MT if lateral column fusion needed. Skin Bridge: Maintain minimum 4cm skin bridge between incisions to prevent skin necrosis - critical safety measure.
Single Incision Technique (Isolated 1st TMT Fusion)
6-8cm dorsomedial longitudinal incision centered over 1st TMT joint, from mid-1st MT shaft to naviculocuneiform joint. Allows isolated 1st TMT exposure with less soft tissue disruption. Cannot access middle/lateral columns adequately.
Superficial Dissection
Deepen through subcutaneous tissue using sharp dissection with scalpel or Metzenbaum scissors. Preserve dorsal subcutaneous veins when possible using gentle retraction - venous congestion increases edema and wound complications. Ligate small perforating veins with bipolar cautery. In lateral incision, identify and protect superficial peroneal nerve branches - typically 2-3 branches crossing surgical field. Mark with vessel loops for constant awareness.
Deep Dissection and Neurovascular Identification
Medial Approach to Dorsalis Pedis
Identify EHL tendon medially (largest, most medial extensor) and EDL to 2nd toe laterally. Palpate dorsalis pedis pulse in 1st-2nd interspace. Develop internervous interval between EHL and EDL using spreading technique with Metzenbaum scissors. Deepen to 12-15mm where neurovascular bundle identified running on first dorsal interosseous muscle. Deep peroneal nerve lies immediately lateral to artery (usually 2-3mm separation).
Neurovascular Protection Strategy
Carefully mobilize dorsalis pedis and deep peroneal nerve using gentle blunt dissection with vessel loops proximally and distally. Create 3-4cm segment of mobilization allowing retraction medially or laterally as needed during joint preparation. Place under vessel loops for constant identification. Position nerve-safe retractors (e.g., Army-Navy, mini-Hohmann) to protect structures. Check pulse frequently to ensure no compression or stretch injury.
Capsular Exposure
After neurovascular protection secured, expose TMT joint capsules. Capsules are thickened in arthritic joints. Use periosteal elevator to elevate capsule from dorsal metatarsal and cuneiform surfaces. Incise capsules longitudinally over each joint to be fused (1st, 2nd, 3rd TMT). If lateral column needed, divide EDB muscle belly in line with its fibers for exposure.
Joint Preparation
Osteophyte Removal
Remove dorsal and medial osteophytes using osteotome, rongeur, or power burr. Complete osteophyte removal improves joint visualization, allows assessment of articular surfaces, and facilitates cartilage removal. Creates space for retractor placement.
Synovectomy and Debridement
Perform thorough synovectomy using arthroscopic shaver (if available) or hand curettes. Remove inflammatory synovium, fibrous tissue, loose bodies, and debris. In post-traumatic cases, often dense scar tissue filling joint space requiring sharp excision. Copious irrigation maintains clear field.
Fish-Scale Cartilage Removal Technique
The fish-scale technique provides systematic complete cartilage removal while preserving bone stock. Use curved osteotomes (6mm, 10mm widths) along cartilage-bone interface. Start peripherally at joint margins, advance osteotome parallel to subchondral bone, remove cartilage in strips creating fish-scale pattern. Work circumferentially around joint from periphery to center. Continue until all cartilage removed to bleeding cancellous bone.
Subchondral Plate Management
Curette remaining cartilage and fibrous tissue from subchondral bone. Avoid aggressive curettage penetrating deep into subchondral bone (weakens structural integrity). Use power burr with saline irrigation to freshen bone ends and expose punctate bleeding (paprika sign). Fenestrate subchondral bone using 2.0mm drill bit making 5-6 perforations per joint surface without penetrating far cortex - promotes vascular invasion and healing without structural weakening.
Joint Surface Shaping
Shape cuneiform and metatarsal base surfaces for broad contact area. Medial cuneiform typically oval-shaped - flatten with rongeur to increase surface area. Middle and lateral cuneiforms require less shaping. Metatarsal bases shaped to match cuneiform surfaces. Preserve metatarsal length - excessive resection shortens foot, alters biomechanics, and weakens fixation. Frequent trial reduction to assess bone-to-bone contact and identify gaps.
Deformity Assessment
Common patterns include flatfoot deformity with medial column collapse and abduction, cavovarus with excessive 1st MT plantarflexion, and post-traumatic malunion in various planes. Assess flexibility with manual correction - determines whether soft tissue releases needed.
Correction Techniques
Flatfoot Correction: Plantar translate and plantarflex 1st MT to restore medial longitudinal arch height. May require plantar fascial release or Achilles lengthening if hindfoot equinus present. Cavus Correction: Dorsiflexion of 1st MT and elevation of medial column. May require dorsiflexion osteotomy if fixed deformity. Rotational Correction: Derotate forefoot to neutral alignment with hindfoot.
Tripod Foot Alignment Goals
The tripod foot concept defines optimal alignment. Three weight-bearing points are calcaneus, 1st MT head, and 5th MT head forming stable triangular base. On lateral fluoroscopy, 1st MT should be plantarflexed 5-10 degrees relative to lesser MTs (measured as angle between 1st MT axis and 2nd-5th MT axis). On AP fluoroscopy, medial border of 1st MT aligns with medial border of medial cuneiform; medial border of 2nd MT aligns with medial border of middle cuneiform; lateral border of 4th MT aligns with lateral border of cuboid. On oblique view, no rotational malalignment and all borders aligned.
Provisional Fixation
After achieving satisfactory alignment, place 0.062-inch or 1.6mm K-wires across each joint in corrected position. Typically 2 divergent K-wires per joint provides stability during definitive fixation. Bend wires outside skin to prevent migration. Check fluoroscopy AP, lateral, and oblique views to confirm alignment before definitive fixation.
Bone Grafting
Indications for Bone Graft
Large defects from debridement, bone loss, or deformity correction. Osteoporosis or poor bone quality. High-risk patients: smokers, diabetics, elderly, steroid users, revision surgery, neuropathic arthropathy. Some surgeons routinely use bone graft in all TMT fusions to optimize union rates.
Autograft Sources
Local Graft: Morselized osteophytes removed from cuneiforms and metatarsal bases provide excellent autograft with no donor site morbidity. Calcaneal Graft: Percutaneous harvest from calcaneus through small stab incision using trephine or curettes. Minimal donor morbidity. Iliac Crest: For large defects requiring structural or significant cancellous graft. Anterior or posterior iliac crest harvest through separate incision. Discuss donor site pain and complications with patient pre-operatively.
Allograft and Biologics
Allograft cancellous chips provide osteoconductive scaffold without donor morbidity. Demineralized bone matrix (DBM) has osteoinductive properties. Bone marrow aspirate from iliac crest or calcaneus provides stem cells and growth factors - can be mixed with allograft. BMP (bone morphogenetic protein) use is off-label for TMT fusion but some evidence supports use in high-risk non-union cases. Concerns include ectopic bone formation, soft tissue swelling, wound complications, and cost.
Grafting Technique
Pack cancellous autograft into joint space after provisional fixation to fill defects and voids. Ensure intimate bone-to-bone contact before grafting - graft should fill gaps not replace contact. Avoid overpacking which prevents compression. Mix graft with bone marrow aspirate if available to enhance biology.
Internal Fixation
Plate Fixation
Dorsal Plates - Standard Technique: Low-profile 2.7-3.5mm dorsal locking or non-locking plates placed longitudinally across each TMT joint. 1st TMT: dorsomedial plate from medial cuneiform to 1st MT, typically 4-6 hole plate. 2nd TMT: dorsal plate or bridge plate connecting 1st and 2nd MT. 3rd TMT: optional plate or screw-only fixation. Contour plate precisely to bone using plate benders to prevent gaps. Place proximal screws in cuneiform first, then apply pointed reduction clamp to compress joint, then place distal screws in metatarsal while maintaining compression. Locking screws in osteoporotic bone provide better purchase. Non-locking screws allow compression and adequate in normal bone.
Plantar Plates - Advanced Technique: Biomechanically superior (tension side plating) but technically demanding with higher neurovascular risk. Requires plantar medial approach between abductor hallucis and FHL, careful neurovascular dissection, and plate placement under direct vision. Reserve for revision cases, high-demand patients, or after failed dorsal fixation. Not routinely recommended due to complication risk.
Screw Fixation
Lag Screw Technique: 3.5mm cortical screws placed across joints using lag technique for interfragmentary compression. Drill pilot hole with 2.5mm drill bit through near cortex across joint into far cortex. Measure depth with depth gauge. Overdrill near cortex with 3.5mm drill bit to create gliding hole. Tap far cortex with 3.5mm tap. Insert 3.5mm cortical screw - threads purchase only far cortex, screw head compresses near cortex creating lag effect.
Screw Trajectories: (1) Medial cuneiform to 1st MT: plantar-medial to dorsal-lateral oblique orientation. (2) Medial cuneiform to 2nd MT base: Lisfranc screw position replicating native ligament orientation, plantar-medial to dorsal-lateral. (3) Middle/lateral cuneiform to 2nd/3rd MT: dorsal to plantar or oblique trajectories as anatomy allows. Bicortical purchase essential for adequate pull-out strength.
Screw Length Considerations: Check screw length on lateral fluoroscopy before final tightening. Plantar penetration should not exceed 3-5mm to avoid neurovascular injury. For 1st TMT screws, typical length 35-45mm. For 2nd TMT Lisfranc screw, typical length 40-50mm. Use depth gauge meticulously.
Combined Fixation
Combined plate and screw constructs provide superior stability with highest fusion rates (90-95% in studies). Plates resist bending and shear forces. Lag screws provide compression and rotational stability. Typical construct: dorsal plate on 1st TMT with adjunctive lag screw from medial cuneiform to 1st MT; dorsal plate on 2nd TMT or Lisfranc lag screw from medial cuneiform to 2nd MT base; screw fixation or mini-plate for 3rd TMT if fused.
Lateral Column Management
Assessment of 4th-5th TMT Joints
Pre-operative CT and intra-operative inspection determine lateral column involvement. Test joint mobility and crepitus. Assess for arthritic changes (cartilage loss, sclerosis, osteophytes).
Preservation Strategy
If 4th-5th TMT joints have minimal arthritis and no pre-operative lateral column pain, PRESERVE MOTION. Lateral column provides 15-20 degrees critical for gait adaptation on uneven surfaces and shock absorption. Fusing lateral column unnecessarily creates rigid painful foot with altered gait mechanics, increased stress on adjacent joints, and potential metatarsalgia.
Selective Fusion Technique
If symptomatic 4th-5th TMT arthritis present (pain with palpation, radiographic arthritis), fuse using one of three techniques: (1) Temporary K-wire fixation for 6 weeks then remove - maintains reduction during healing without rigid fusion. (2) Bridge plate without compression - stabilizes but allows micromotion promoting fibrous union. (3) Lag screw with compression - creates rigid fusion. Choice depends on degree of arthritis and instability.
Final Confirmation and Closure
Systematic Fluoroscopic Assessment
AP View: (1) Medial border 1st MT aligns with medial border medial cuneiform (no step-off). (2) Medial border 2nd MT aligns with medial border middle cuneiform. (3) Lateral border 4th MT aligns with lateral border cuboid. (4) No diastasis between metatarsal bases. (5) Hardware position appropriate - screws centered in bone, plates positioned correctly.
Lateral View: (1) 1st MT plantarflexed 5-10 degrees relative to lesser MTs (tripod alignment). (2) No dorsal or plantar subluxation. (3) Screw lengths appropriate - plantar penetration minimal. (4) Restoration of medial longitudinal arch height if flatfoot correction performed.
Oblique View: (1) No rotational malalignment. (2) No intra-articular hardware. (3) Alignment appears congruent from this view.
Image Documentation: Save images for operative report and post-operative comparison.
Wound Closure
Release tourniquet and achieve meticulous hemostasis with bipolar cautery. Hematoma prevention critical for infection risk reduction and healing. Consider closed suction drain if extensive dissection or high bleeding risk (coagulopathy), remove at 24-48 hours. Close joint capsules with interrupted 2-0 absorbable suture if tissue quality adequate - adds stability. Close deep fascia and EDB if divided with 2-0 absorbable interrupted sutures. Subcutaneous layer closed with 3-0 absorbable suture. Skin closed with subcuticular 3-0 absorbable monofilament or interrupted 3-0 nylon sutures.
Dressing and Splinting
Apply sterile gauze, fluffs, and cast padding maintaining web spaces. Apply well-molded short leg plaster splint in neutral ankle position (90 degrees), slight plantarflexion of 1st MT to maintain correction. Three-sided splint (posterior and bilateral) provides better stability than single posterior slab. Wrap with elastic bandage avoiding excessive compression.
Immediate Post-operative Period (0-2 Weeks)
In-Hospital Management
Elevate leg on 3-4 pillows above heart level continuously first 48-72 hours to minimize edema. Ice therapy 20 minutes every 2 hours while awake. Multimodal analgesia: oral opioids first 24-48 hours, transition to acetaminophen and NSAIDs (if fusion risk acceptable - some avoid first 6 weeks). Regional anesthesia (popliteal block) provides excellent initial pain control. Monitor neurovascular status every 4 hours first 24 hours: pedal pulses, capillary refill, sensation, motor function, pain control. Compartment Syndrome Vigilance: TMT surgery can cause compartment syndrome especially with prolonged tourniquet time or significant swelling. Assess for pain out of proportion, pain with passive stretch, tense compartments, paresthesias. Low threshold for compartment pressure measurement if clinical concern.
Discharge Planning
Most patients discharged post-operative day 0-1 if pain controlled and no complications. Strict non-weight-bearing (NWB) with crutches or knee scooter. Continue elevation and ice. Prescribe DVT prophylaxis: aspirin 325mg daily or enoxaparin 40mg daily subcutaneous for 2-3 weeks (higher risk patients). First follow-up appointment at 10-14 days for wound check and radiographs.
Early Healing Phase (2-6 Weeks)
Week 2 Follow-Up
Remove surgical dressing and inspect wounds for healing, dehiscence, infection signs. Clean with normal saline and apply new sterile dressing. Obtain AP, lateral, and oblique weight-bearing (non-weight-bearing positioned) radiographs to confirm maintained alignment and hardware position. Compare to intra-operative fluoroscopy. Transition from splint to short leg cast or removable boot (non-weight-bearing). Continue strict NWB.
Week 6 Follow-Up
Remove K-wires if used for provisional or lateral column fixation under local anesthesia in clinic. Obtain repeat radiographs assessing early healing (subtle blurring of fusion line, early bridging callus may be visible). Continue NWB if no radiographic evidence of healing. If early bridging callus visible in good quality bone, may consider transition to PWB (partial weight-bearing).
Progressive Weight-Bearing Protocol
Week 6-8: If radiographs show early callus formation, begin PWB 25% body weight in boot. Use bathroom scale for feedback. Progress by 25% weekly as tolerated. Continue boot full-time.
Week 8-10: Increase to PWB 50-75% if radiographs show continued healing. Patient typically reports decreased pain with weight-bearing.
Week 10-12: Obtain radiographs assessing union. Signs of solid fusion include: bridging callus visible on 3 of 4 cortices, obliteration of lucent fusion line, trabecular bridging across fusion site. If solid fusion evident, advance to FWB (full weight-bearing) in boot. If questionable union, obtain CT scan - gold standard for assessing bony bridging. Continue PWB and repeat radiographs at 14-16 weeks if union questionable.
Advanced Healing Phase (3-6 Months)
Return to Shoe Wear
Once FWB achieved in boot (typically 10-14 weeks), begin gradual transition to supportive shoes. Stiff-soled shoe or rocker-bottom shoe recommended. Custom orthotics prescribed for most patients (70-80%) to provide arch support, redistribute plantar pressures, and improve comfort. Molded ankle-foot orthosis (AFO) for high-risk patients (neuropathic, osteoporotic, heavy manual labor).
Physical Therapy
Initiate physical therapy at 12-14 weeks focusing on: ankle range of motion (often stiff from prolonged immobilization), strengthening (peroneals, tibialis posterior, gastrocsoleus), proprioception and balance training, gait training with shoe wear, progressive functional activities.
Return to Activities
Driving: May return to driving at 10-12 weeks if right foot and FWB achieved, able to perform emergency stop safely.
Work: Sedentary work with elevation possible at 2-4 weeks. Light duty at 8-12 weeks. Full duty including manual labor at 4-6 months once solid fusion confirmed.
Sport: Low-impact activities (swimming, cycling) at 4-5 months. High-impact activities (running, jumping sports) at 6-9 months. Full return to competitive sport at 6-12 months depending on fusion solidity and functional recovery.
Long-Term Follow-Up
Radiographic Surveillance
Radiographs at 4-6 months, 1 year, then yearly for 3-5 years. Assess for: maintained fusion solidity, hardware position (loosening or breakage), adjacent joint arthritis development (naviculocuneiform, intercuneiform, lesser TMT joints), alignment maintenance.
Hardware Removal
Indications include symptomatic prominent hardware (dorsal plates impinging on shoe wear), painful hardware requiring removal in 5-10% patients. Typically perform at 12-18 months minimum once solid fusion confirmed. Risk of recurrent deformity if removed too early. Some surgeons routinely remove Lisfranc screw from 2nd TMT at 6-12 months to prevent hardware failure, though this is controversial.
Outcome Expectations
Fusion Rate: 85-95% at 12-18 months with modern techniques and fixation.
Pain Relief: 80-90% patients report significant pain improvement. Residual mild pain common but functional.
Function: AOFAS midfoot scores typically 75-85 at 2 years. Return to pre-injury activity level in 70-80%.
Satisfaction: 80-90% patient satisfaction for post-traumatic arthritis. Lower satisfaction (60-70%) for primary OA and inflammatory arthropathy due to progressive disease.
Complications: See complications section for detailed discussion of adverse outcomes.
Key Studies
Fusion Rates and Techniques
Ly and Coetzee (2006) - Systematic review of TMT arthrodesis techniques. Reported overall union rate 88% (range 80-97%) across multiple studies. Isolated 1st TMT fusion union rate 90-95%. Multi-ray fusion (1st-2nd-3rd TMT) union rate 85-90%. Higher non-union rate in lateral column fusions (4th-5th TMT) at 75-85%, supporting selective preservation when possible.
Komenda et al. (1996) - Compared screw fixation alone versus plate fixation for TMT arthrodesis. Screw-only group: 83% fusion rate. Plate-only group: 90% fusion rate. Combined plate-screw group: 95% fusion rate. Recommended combined constructs for optimal stability and fusion.
Rippstein et al. (2009) - Biomechanical study comparing dorsal versus plantar plate fixation for 1st TMT arthrodesis. Plantar plating demonstrated 40% higher load to failure and 35% less displacement under cyclic loading compared to dorsal plating. However, clinical series showed increased neurovascular complications with plantar approach, limiting widespread adoption.
Alignment and Functional Outcomes
Sangeorzan et al. (1989) - Landmark study on Lisfranc injury outcomes. Demonstrated that anatomic reduction within 2mm predicts excellent outcomes in 90%, while reduction 2-5mm achieves good outcomes in only 60%, and greater than 5mm results in poor outcomes in 75%. Emphasizes critical importance of precise alignment.
Mulier et al. (2002) - Long-term outcomes study of post-traumatic TMT arthrodesis with mean 8-year follow-up. AOFAS scores averaged 78 points. 85% patient satisfaction. 15% developed adjacent joint arthritis (primarily naviculocuneiform). Predictors of poor outcome included: diabetes, smoking, worker's compensation, lateral column fusion.
Klaue (2009) - Described tripod foot concept for TMT fusion alignment. Emphasized 1st MT plantarflexion 5-10 degrees relative to lesser MTs on lateral radiograph. Found that dorsiflexion malunion greater than 5 degrees correlated with transfer metatarsalgia in 80% of cases, often requiring revision osteotomy.
Complications Evidence
Non-Union Risk Factors
Shibuya et al. (2012) - Retrospective cohort of 203 TMT arthrodesis patients. Overall non-union rate 12%. Multivariate analysis identified independent risk factors: smoking (OR 3.8), diabetes (OR 2.9), osteoporosis (OR 2.4), screw-only fixation (OR 2.1). Combined plate-screw fixation reduced non-union risk by 60% compared to screws alone.
Hunt et al. (2009) - Meta-analysis of TMT fusion techniques. Non-union rates by fixation method: screws alone 15%, plates alone 10%, combined plate-screw 5%. By patient factors: non-smokers 8%, smokers 22%, diabetics 18%, neuropathic arthropathy 25%. Recommended smoking cessation minimum 6 weeks pre-operatively and consideration of biologics in high-risk patients.
Adjacent Joint Arthritis
Henning et al. (2007) - Long-term radiographic study with minimum 5-year follow-up post-TMT fusion. Adjacent joint arthritis developed in 25% patients. Most common site: naviculocuneiform joint (18%). Less common: intercuneiform (8%), lesser TMT (5%). Risk factors: multi-ray fusion (3 or more joints), inflammatory arthropathy, malalignment. 40% of patients with adjacent arthritis required extension of fusion.
Australian Context
AOANJRR Data
The Australian Orthopaedic Association National Joint Replacement Registry does not specifically track TMT arthrodesis as it focuses on arthroplasty. However, ankle arthrodesis data shows fusion rates comparable to international literature (85-90%) and emphasizes importance of patient factors (diabetes, smoking) as major determinants of outcome.
MBS Item Numbers
MBS 49554: Arthrodesis of tarsometatarsal joint, isolated (e.g., 1st TMT alone). Medicare rebate approximately AUD 1,100. Total out-of-pocket costs in private system AUD 4,000-7,000.
MBS 49557: Arthrodesis of tarsometatarsal joints, multiple (e.g., medial column 1st-2nd-3rd TMT). Medicare rebate approximately AUD 1,400. Total private costs AUD 5,500-9,000.
Additional costs include hospital fees, anesthesia, imaging, hardware, post-operative therapy. Public hospital system provides surgery without out-of-pocket costs but waiting times typically 6-12 months for elective cases.
PBS Considerations
Post-operative analgesia typically includes paracetamol (PBS listed) and oxycodone (PBS listed Schedule 8 - requires authority prescription). NSAIDs (ibuprofen, diclofenac) PBS listed but controversial in fusion first 6-8 weeks due to theoretical non-union risk. DVT prophylaxis with enoxaparin (Clexane) PBS listed with authority for orthopedic surgery indications.
eTG Antibiotic Guidelines
Prophylaxis: Single dose cefazolin 2g IV within 60 minutes of incision (Therapeutic Guidelines: Antibiotic). Vancomycin 25-30mg/kg IV if penicillin allergy or MRSA risk.
Treatment of Infection: Deep infection requires surgical debridement with bone/tissue cultures, empiric therapy with flucloxacillin 2g IV q6h plus ciprofloxacin 400mg IV q12h pending cultures, de-escalate based on sensitivities, total duration 6-12 weeks IV followed by oral suppression in some cases.